ArticleBlood2022
Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen.
Barbara Simon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papertrialcites it
ArticleBlood2022
Barbara Simon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.